DUBLIN, Ireland –Medtronic’s hybrid closed loop system for people with Type 1 diabetes is now available in the U.S., following approval by the U.S. Food and Drug Administration last year. “We’ve essentially designed a smarter insulin pump that alleviates some of the burden associated with diabetes management, which can be unrelenting and exhausting,” said Alejandro Galindo, president of the Intensive Insulin Management division within the Diabetes Group at Medtronic, in a statement. The MiniMed670G features the company’s most advanced SmartGuard HCL technology and Guardian Sensor 3 to self-adjust basal insulin delivery every five minutes based on real-time needs. Through this personalized design, the system is able to maximize the amount of time sugar levels stay within a range considered healthy by clinical standards. The system also exclusively features the Contour Next Link 2 blood glucose monitoring system from Ascensia Diabetes Care.
You are here: / / Medtronic closed loop insulin system now available